SMP-3124LP in Adults With Advanced Solid Tumors

ClinicalTrials.gov ID: NCT06526819

Public ClinicalTrials.gov record NCT06526819. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 3, 2026, 6:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Phase 1 Dose Escalation and Phase 2 Dose Expansion Study to Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of SMP-3124LP in Adults With Advanced Solid Tumors

Study identification

NCT ID: NCT06526819
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Enrollment: 120 participants

Conditions and interventions

Conditions

Solid Tumor

Interventions

SMP3124LP Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 13, 2024
Primary completion: Nov 30, 2028
Completion: Apr 30, 2029
Last update posted: Feb 26, 2026

2024 – 2029

United States locations

U.S. sites: 8
U.S. states: 7
U.S. cities: 7

Facility	City	State	ZIP	Site status
Cedars Sinai Medical Center	Los Angeles	California	90048	Recruiting
Sarah Cannon Research Institute at HealthOne	Denver	Colorado	80218	Recruiting
Northwestern Medicine Cancer Center	Chicago	Illinois	60611	Recruiting
Ohio State University	Columbus	Ohio	43210	Recruiting
SCRI Oncology Partners	Nashville	Tennessee	37203	Recruiting
Vanderbilt-Ingram Cancer Center	Nashville	Tennessee	37232	Recruiting
MD Anderson Cancer Center	Houston	Texas	77030	Recruiting
University of Washington	Seattle	Washington	98105	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06526819, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 26, 2026 · Synced May 3, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06526819 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →